ABSTRACT: A biopsy procedure was developed to enable repeated sampling of a single equine corpus luteum (CL) over the course of an estrous cycle. The tissue collected was utilized in characterizing mRNA abundance for genes involved in luteal formation, function, and regression in the cyclic mare. Serial biopsies of CL in cyclic mares (2.7 to 27.5 mg per biopsy) were collected using an ultrasound-guided transvaginal technique. Biopsies were collected from each mare on d 2 and 5 (d 0 = ovulation) of the estrous cycle, and every other day from d 12 through luteolysis. Samples were obtained from 4 mares with normal estrous cycles and 1 mare with a retained CL. The biopsy procedure did not adversely affect luteal size or function, as measured by luteal area and serum concentrations of progesterone. Real-time reverse-transcription PCR was used to quantify steady state mRNA concentrations in each tissue sample obtained. Mean abundance of steroidogenic acute regulatory protein (StAR) mRNA was not different (P = 0.102 to 0.964) on any of the sampling dates, but a trend for mRNA encoding StAR to decrease between d 12 and 14 (P = 0.10) was observed. Values for mRNA encoding StAR were positively correlated to serum concentrations of progesterone on d 5 (R = 0.95; P = 0.05) and 14 (R > 0.99; P < 0.01). Steady-state abundance of mRNA for 3β-hydroxysteroid dehydrogenase, Δ 5-Δ 4 isomerase (3β-HSD) declined between d 12 and 14 (P = 0.15). There were positive correlations between mRNA for 3β-HSD and concentrations of progesterone on d 5 (R = 0.94; P = 0.06) and 12 (R > 0.99; P = 0.05). No difference was detected in abundance of mRNA encoding cyclooxygenase-2 (cox-2; P = 0.340 to 0.840) or caspase-3 (P = 0.517 to 0.882) between any of the sampling dates. A successful luteal biopsy procedure was developed that did not negatively affect luteal function, and abundance of mRNA encoding StAR, 3β-HSD, cox-2, and caspase-3 was characterized in luteal biopsy tissue collected on d 2, 5, 12, and 14 of the estrous cycle in the mare.
INTRODUCTION
Progesterone is synthesized in the corpus luteum (CL) from the precursor cholesterol. Steroidogenic acute regulatory protein (StAR) is involved in the transportation of cholesterol to the inner mitochondrial membrane, which is the rate-limiting step of steroidogenesis (Stocco and Clark, 1996a) . The enzyme 3β-hydroxysteroid dehydrogenase, Δ 5-Δ 4 isomerase (3β-HSD) is responsible for the conversion of pregnenolone to progesterone in the smooth endoplasmic reticulum.
The CL also produces PG, particularly during the early stages of the estrous cycle and during luteolysis (Wiltbank and Ottobre, 2003) . The rate-limiting step in PG production is the conversion of arachidonic acid to PGG 2 by cyclooxygenase-2 (cox-2), the inducible, highly regulated form of cox (Wiltbank and Ottobre, 2003) . Activation of caspase-3 leads to the cleavage of key proteins during luteolysis, such as actin and poly ADP-ribose, in the cell (Casciola-Rosen et al., 1996) .
Previous work describing luteal mRNA abundance used CL surgically extracted from the ovary at predetermined stages of the estrous cycle, with most of this work performed in nonequine species (Tian et al., 1994; Juengel et al., 1995 Juengel et al., , 2000 Wiltbank, 1997, 1998; Juengel and Niswender, 1999; Diaz et al., 2000; Kobayashi et al., 2002; Narayansingh et al., 2002; Galvao et al., 2008; Berisha et al., 2010) . The limitation of this technique was that the same CL could not be sampled repeatedly. The ultrasound-guided serial biopsy technique used by Beg et al. (2005) and in the current experiment overcomes this limitation.
The following investigation was designed to characterize mRNA abundance for StAR, 3βHSD, cox-2, and caspase-3 through repeated sampling of the equine CL over the course of the estrous cycle.
MATERIALS AND METHODS
All animal procedures were approved by the Colorado State University Animal Care and Use Committee.
A total of 6 mature, stock-type mares were utilized in this study. The mares were fed a diet of alfalfa hay, housed in the Northern hemisphere (40°45′ N, 105°5′ W), and the experiment was conducted during the months of June through September.
The ovaries of 5 cyclic mares were examined daily by rectal ultrasound evaluation to determine date of ovulation. Initially 3 mares were assigned to a biopsy group and 2 mares were assigned to a control group. A switchback design was utilized in which each mare was then assigned to the opposite group during her subsequent estrous cycle. The first mare to ovulate was assigned to the biopsy treatment group, the second mare to ovulate was designated as a control, and the treatments were alternated according to ovulation date in an effort to reduce any seasonal effects.
During each control cycle, the area of the CL was monitored by transrectal ultrasonography using an Aloka SSD-500v machine with a 5MHz probe (Tokyo, Japan). The largest diameter of each CL was measured on alternating days from d 2 (d 0 = ovulation) until the subsequent ovulation, with an additional examination on d 5. Luteal diameter was divided by 2 to determine radius (r), which was then used in the formula πr 2 to calculate luteal area. Blood was collected (10 mL) daily via jugular venipuncture for quantification of serum concentration of progesterone. Blood was allowed to clot at room temperature for 1 to 2 h or at 4°C overnight and centrifuged at 3,000 × g for 15 min at room temperature. Serum was removed and stored at −20°C until measurement of progesterone concentration by RIA (Niswender, 1973) . Three mares had abnormal control cycles characterized by a retained CL or luteinized follicles. Data collected from these cycles were excluded from analysis. A retained CL was defined by serum progesterone above 1 ng/mL and a luteal structure visible upon ultrasound evaluation past d 25 of the estrous cycle. Because of the number of abnormal, and therefore excluded, cycles, an additional mare was monitored for a control cycle. This provided data from a total of 3 control mares suitable for analysis.
The mares assigned to the biopsy group were subjected to the same ultrasound evaluation and blood collection regimen as the control mares. Additionally, luteal biopsies were collected on d 2 and 5 of the estrous cycle, and then on alternating days from d 12 until each CL was too far regressed for biopsy. The procedure described for sampling the CL of cows (Kot et al., 1999; Tsai et al., 2001) was modified in the current experiment for use in the mare. During the biopsy procedure, mares were restrained in palpation stocks and administered 1.1 mg/kg of BW flunixin meglumine (Flunixamine, Fort Dodge Animal Health, Fort Dodge, IA) approximately 10 to 15 min before the procedure. Mares were also administered preanesthetic medication [0.44 mg of xylazine hydrochloride (Sedazine, Fort Dodge Animal Health)/kg of BW, 0.016 mg of butorphanol tartrate (Torbugesic, Fort Dodge Animal Health)/kg of BW, and 0.044 mg of propanthaline bromide/kg of BW] 3 to 5 min before the procedure. Each mare was twitched and the tail wrapped in a fingerless plastic sleeve to prevent contamination of the ultrasound probe/needle apparatus (5 MHz ultrasound transducer, plastic handle, and 60-cm, 18-gauge spring-loaded biopsy needle from US Biopsy, SABD-1860-15-T, Franklin, IN). The rectum was evacuated and the perineal area washed using povidone-iodine soap (Betadine, Purdue Frederick, Norwalk, CT). After drying the perineal area, a technician introduced the ultrasound probe/needle apparatus into the vagina using a sterile sleeve and sterile lubricant. The apparatus was maneuvered through the vagina until it reached the vaginal fornix. The technician grasped the ovary of the mare containing the CL to be biopsied, per rectum, and manipulated the ovary to align the biopsy device with the CL. The needle was inserted through the vaginal wall and into the CL. The spring-loaded attachment was released and a luteal biopsy acquired. Each biopsy required approximately 3 to 5 min to complete. Four mares demonstrated normal luteal regression during their biopsied cycles and tissue samples were collected until d 14 to 16; the fifth mare had a retained CL. Luteal biopsies were collected from this mare until d 20, but data collected from this abnormal estrous cycle were not included in the statistical analysis.
Immediately after the acquisition of luteal tissue, the sample was removed from the biopsy device with hydrogen peroxide-treated forceps and placed in diethyl pyrocarbonate (Depc)-treated PBS. The biopsy tissue was examined under a dissecting microscope and any ovarian stromal tissue removed. Luteal tissue was placed into a 1.7-mL Eppendorf tube and weighed. The tube containing the sample was plunged into liquid nitrogen and stored at −80°C until analysis.
PCR Analysis
Ribonucleic acid extracted from the equine luteal tissue samples was subjected to real-time reverse-transcription (RT) PCR to quantify steady-state abundance of mRNA encoding StAR, 3β-HSD, cox-2, and caspase-3. Each tissue sample was homogenized with a VirTis Handishear tissue homogenizer (VirTis, Gardiner, NY), and RNA was isolated following the manufacturer's directions for TriReagent (Sigma-Aldrich, St. Louis, MO). Immediately after RNA isolation, the RNA was treated with TURBO DNase reagent (Ambion, Austin, TX) for 30 min at 37°C to remove any genomic DNA from the sample. The RNA was quantified by measuring the optical density at 260 nm with a spectrophotometer. After RNA isolation, DNase treatment, and quantification, the RNA was stored at −80°C.
Isolated RNA was converted to cDNA using RT. One microgram of RNA was used in each 40-µL RT reaction. Of the 30 tissue samples, less than 1 µg of RNA was extracted from 6 samples; in these cases, all RNA obtained from the sample was included in a 40-µL RT reaction. Water treated with Depc was added to each RNA sample to bring the total volume to 25 µL. The RNA and water were heated to 65°C for 10 min to remove any secondary structure. Reverse transcription reaction components were then added: 300 units of MMLV enzyme (Moloney murine leukemia virus, Promega, Madison, WI), 1X MMLV buffer (Promega), 1 mM dNTP (Promega), 37 units of ribonuclease inhibitor (Fisher Scientific, Fair Lawn, NJ), 0.375 µg of random primers (Invitrogen, Carlsbad, CA), and 0.001 M dithiotheitol. Each RT reaction was incubated at 42°C for 1 h. The MMLV enzyme was heat inactivated at 95°C for 10 min. Sixty microliters of Depc-treated water was added to the final product to bring the total volume to 100 µL. The resulting cDNA was stored at −80°C until PCR analysis.
Standards for each gene were generated from DNA cloned into a plasmid (PGEM-T, Promega, or pCR 3.1, Invitrogen). The equine StAR vector was kindly donated by Jean Sirois (Universite de Montreal, Montreal, Canada). The sequences for equine 3β-HSD (Accession number D89666 D89665) and cox-2 (Accession number AB041771) were available in GenBank (National Center for Biotechnology Information, Bethesda, MD), and primers were designed based on reported sequences (Table 1) . These primers were used in PCR with equine cDNA to yield a DNA product, which was subcloned into the PGEM-T plasmid (#A3600, Promega) and competent Escherichia coli cells were then transformed with the plasmid. A midi-culture of transformed cells was grown and the plasmid isolated (Plasmid Midi Kit #12143, Qiagen Inc., Valencia, CA). The plasmid DNA was sequenced (Davis Sequencing, Davis, CA) to ensure the DNA obtained corresponded with the known sequence for the gene of interest. The plasmid was subjected to an in vitro transcription reaction (MegaScript T7 kit #1333, Ambion) to generate cRNA. The cRNA was quantified using the spectrophotometer reading. Known amounts of each cRNA were placed into 2 separate RT reactions, carried out as described previously.
The same process was used to generate a caspase-3 standard, with 1 modification. The equine caspase-3 sequence had not been reported. Thus, degenerate primers were designed based on the sequences known for other species. The primer sequences 5′GTGMT-TCTAAGYCATGGDGAWGAAGG3′ and 5′CCYCG-GCAGGCCTGAATRATGAARAG3′ yielded a product that was then subcloned into PGEM-T, sequenced, and standards were created using the described previously methods.
Ribosomal protein S15 was used as a housekeeping gene to correct for differences in starting quantities of total RNA. The S15 is a protein that makes up part of the small ribosomal subunit and is stable under several conditions (Wright et al., 2008) . The bacterial homolog, S19, is involved in the initiation and elongation elements of translation (Hirano et al., 1987) . The sequence of equine S15 had not been reported, so ovine S15 primers were used in PCR with equine cDNA to generate a DNA product. This product was submitted for sequencing and was highly homologous to other known S15 sequences. This product was then used to generate equine S15 standards.
To quantify steady-state mRNA abundance in the luteal samples, real-time PCR was used to measure the amount of cDNA in each sample corresponding to each target gene. Each PCR reaction included 5 µL of RT product, 1X iQ SYBR Green Supermix (catalog #170-8882, BioRad, Hercules, CA), 0.2 µM each of the forward and reverse primers, and water to bring the total volume to 25 µL. Each sample was loaded in triplicate into a 96-well plate. A thermal cycler (iCycler, BioRad) was used to carry out the thermal cycling and measure fluorescence emitted from SYBR green (SYBR green binds nonspecifically to double-stranded DNA, so as the cDNA is amplified, there is a corresponding increase in fluorescence). 
Gene
Primer sequence
Genes of interest included steroidogenic acute regulatory protein (StAR), 3β-hydroxysteroid dehydrogenase, Δ 5-Δ 4 isomerase (3β-HSD), cyclooxygenase-2 (cox-2), and caspase-3. The first sequence for each gene listed is the forward primer, followed by the reverse primer.
Each PCR began with 3 min at 95°C, followed by 50 cycles of 15 s at 95°C (melting), 45 s at 58°C (annealing), and 30 s at 72°C (extension). Fluorescence data were collected while the samples were at 72°C during each cycle. After 50 cycles, a melt curve was generated. The melt curve began at 55°C, and the temperature was increased by 0.5°C every 10 s. The temperature was increased 80 times and fluorescence data collected at each temperature. The melt curve identified the temperature at which the PCR products melted apart, thus giving an indication of the size and number of products obtained in each well. Any wells that produced aberrant melt curves (compared with the other samples in the same plate for the same gene) were excluded from analysis.
In each 96-well PCR plate, the serially diluted points from both sets of standards were run in duplicate. An arbitrary fluorescence threshold was determined for each plate, and the cycle number at which the fluorescence in each individual well reached that threshold was designated as the Ct value for that sample. Starting quantities of mRNA in unknown samples were calculated with the software associated with the thermocycler (BioRad) by comparing the Ct value for unknown samples against the standard curve. The calculated starting quantities for triplicate wells were averaged and normalized to S15 to determine relative quantities of the target mRNA.
Progesterone Assay
Concentrations of progesterone were determined in serum samples for each mare using RIA (Niswender, 1973) . Samples were run in duplicate in a single assay, and the intraassay CV was 18.4%.
Statistical Analysis
A Fisher's protected LSD was used to compare serum concentrations of progesterone and CL area between treatment groups and between days. Messenger RNA values from the real-time RT-PCR analysis were normalized to S15, log-transformed, and compared with Fisher's protected LSD using repeated measures (SAS Inst. Inc., Cary, NC). Significance was determined as P < 0.05, and tendencies were determined as P < 0.10.
RESULTS

Progesterone and Luteal Area
Patterns of progesterone secretion were similar (Pvalues varied from 0.105 to 0.85 depending on day) for mares in both treatment groups (Figure 1) , and there was no difference in mean serum concentrations of progesterone between groups from d 3 to 12, except on d 9 when the biopsied mares had less progesterone than control mares (P = 0.02). When area under the curve (AUC) was calculated for progesterone, the average AUC for mares in the biopsy treatment group was 55.21 and the mean AUC for mares in the control group was 72.08, which were not different from one another (P = 0.51). Mean concentration of progesterone was greater than 4 ng/mL throughout the luteal phase for both groups of mares and declined in both groups between d 12 and 13 (P = 0.01 in biopsied mares and P = 0.0005 in control mares), at the time of expected luteolysis.
Analysis of luteal area revealed no differences in size between CL of mares in biopsy and control cycles on any day (P = 0.16 to 0.69; Figure 2) . A reduction in CL area was first detected between d 10 and 12 (P = 0.01) in control mares, whereas the biopsied CL were delayed by 1 measurement period with the first reduction in area detected between d 12 and 14 (P = 0.01). The mean interovulatory interval was 20.5 d in the biopsy treatment group and 23 d in the mares assigned to the control group (P = 0.08).
mRNA
The mRNA data collected for each gene of interest were normalized by dividing femtomoles of the gene of interest by femtomoles of S15 within the same sample. After collecting the PCR data and quantifying abundance of S15 mRNA, it became apparent that S15 mRNA abundance was only consistent until d 14, after which point it decreased (Figure 3) . Due to the variability among samples, this decline in mRNA encoding S15 was not significant (P > 0.20), but it was of large enough magnitude to be of concern. Thus, data collected from biopsies taken after d 14 were excluded from analysis. Mean serum concentrations of progesterone in mares during their control (n = 3) and biopsy (n = 4) cycles. The only difference between groups was detected on d 9 (P = 0.02). Area under the curve was not different between groups (P = 0.51). Serum concentrations of progesterone declined between d 12 and 13 in mares during the control (P = 0.0005) and biopsy cycles (P = 0.01).
Mean abundance of StAR mRNA was not different (P-values varied from 0.102 to 0.968) on any of the sampling dates (Table 2) , but there was a trend for mRNA encoding StAR to decrease between d 12 and 14 (P = 0.10). Values for mRNA encoding StAR were positively correlated to serum concentrations of progesterone on d 5 (R = 0.95; P = 0.05) and 14 (R > 0.99; P < 0.01). Abundance of mRNA for 3β-HSD declined between d 12 and 14 (P = 0.15). There were positive correlations between mRNA for 3β-HSD and concentrations of progesterone on d 5 (R = 0.94; P = 0.06) and 12 (R > 0.99; P = 0.05). There was no difference (P = 0.34 to 0.84) detected in abundance of mRNA encoding cox-2 or caspase-3 between any of the sampling dates (Table 2 ).
In the single retained CL, abundance of mRNA for StAR and 3β-HSD appeared to peak earlier than was detected in the normal CL and cox-2 expression appeared to be less in the retained CL on d 5 and 12. Otherwise there were no obvious differences between the retained CL and the normal CL in the abundance of mRNA for any of the genes evaluated (Table 2) .
DISCUSSION
Ultrasound-guided biopsy has been used to sample the gastrointestinal tract in small animals (Penninck et al., 1993) , the liver and kidney of dogs (Hoppe et al., 1986) , and luteal tissue in cattle (Kot et al., 1999; Tsai et al., 2001 ) and mares (Beg et al., 2005) . Although there was considerable variability in the amount of tissue collected per biopsy (2.7 to 27.5 mg) in this experi- Messenger RNA encoding steroidogenic acute regulatory protein (StAR), 3β-hydroxysteroid dehydrogenase, Δ 5-Δ 4 isomerase (3β-HSD), cyclooxygenase-2 (cox-2), and caspase-3 were measured. All values were normalized against femtomoles of S15, which was used as a housekeeping gene. ment, each yielded enough tissue to quantify steadystate abundance of mRNA encoding 5 different genes using real time RT-PCR. No follicles of preovulatory size (>35 mm) were detected in any mare during the luteal phase of the estrous cycle, no asynchronous ovulations were observed, and no secondary CL were noted during the ultrasound evaluations, thus ensuring that the same CL was measured and biopsied throughout each cycle. All CL were sampled until d 14 and only 2 CL were sampled on d 16 (excluding the retained CL). Others who have utilized a similar luteal biopsy procedure in the mare performed multiple biopsy procedures on all mares on each sampling date (Beg et al., 2005) , but only 8 of the 26 biopsies (31%) performed in the current experiment required a second attempt. In those instances, a first biopsy procedure yielded primarily stroma, so an additional biopsy was required to obtain luteal tissue. No mares in the current experiment demonstrated signs of discomfort after the procedure, and no luteal or ovarian trauma was visible with ultrasound after any of the procedures. This is in contrast to the effects of intraluteal injection reported by Weber et al. (2001) who found that in response to intraluteal injections of PGF 2α , 3 of 24 (12.5%) mares developed ovarian abscesses.
Progesterone and Luteal Area
Because the mean serum concentration of progesterone and luteal area between the groups of mares were similar, the biopsy procedure did not appear to adversely affect luteal function. Others have reported reduced serum concentrations of progesterone in mares undergoing luteal biopsy (Beg et al., 2005) , but those same researchers biopsied each CL 6 to 10 times per sample obtained, subjecting the CL to more trauma than was induced in the current experiment where a single biopsy was sufficient in most cases and no CL were biopsied more than twice to obtain a sample. Concentrations of progesterone in serum remained above 4 ng/mL throughout diestrus in both groups of mares, values considered adequate to maintain pregnancy in the mare (Ginther, 1992) . Progesterone concentrations declined in both groups between d 12 and 13, indicating the beginning of luteolysis. This decline was expected because mares typically initiate luteolysis around d 14 of the estrous cycle (Ginther, 1992) .
There was no difference in luteal area throughout the estrous cycle between control and biopsied CL, which is in agreement with others who have performed similar procedures in mares (Beg et al., 2005) . Tissue was extracted from the interior section of the CL during each biopsy procedure. It is possible that the void created by tissue extraction was filled with a small volume of fluid or scar tissue (vs. luteal tissue) which would not be detected with ultrasound examinations, but exterior luteal area did not change significantly as a result of the biopsy procedure. A decrease in area was detected between d 10 and 12 for the control CL and between d 12 and 14 for the biopsied CL. In both cases, a decline in luteal area was observed in temporal association with a decline in serum concentration of progesterone. Although luteal area decreased later (d 14 vs. 12) in biopsied CL, there was only a tendency for these mares to have a shorter interovulatory interval than control mares. However, both groups of mares had estrous cycles that would be considered normal length.
Based on serum concentrations of progesterone and luteal area, there were no problems detected in luteal function, growth, or regression associated with the biopsy procedure. Both groups of mares maintained adequate serum concentrations of progesterone to theoretically maintain pregnancy. Repeated tissue biopsies in the same CL were successful and could be useful in further research or in clinical applications.
mRNA Abundance
By d 2 to 3 after ovulation, the equine CL is steroidogenic with serum concentrations of progesterone generally exceeding 1 ng/mL, but on d 2 the equine CL will not yet respond to exogenous PG. This refractory period ends by d 5, at which time the administration of exogenous PG will induce luteolysis (Hafs et al., 1974) . On d 12, steroidogenesis is expected to remain increased (Allen and Hadley, 1974; Evans and Irvine, 1975; Noden et al., 1975; Nett et al., 1976) , and shortly thereafter (around d 14) the CL should undergo luteolysis (Douglas and Ginther, 1976) . The biopsies in the current experiment were targeted at these important benchmark dates in luteal formation and regression.
Whereas S15 has been reported to have the features characteristic of a housekeeping gene (Kitagawa et al., 1991) and has been used as a housekeeping gene by others (Rozance et al., 2007; Wright et al., 2008) , its mRNA abundance was not sufficiently consistent after d 14 to continue utilizing it as a housekeeping gene in this study. The declining concentrations of progesterone and decreased luteal area after d 14 indicate that the CL were undergoing luteolysis. It is possible that luteal cells were undergoing apoptosis and abundance of most mRNA, including S15, were declining at this stage of the estrous cycle.
Steroidogenic acute regulatory protein in the equine CL is localized to large luteal cells (Watson et al., 2000) . Abundance of StAR protein have been investigated in equine follicles, early CL, and pregnant vs. nonpregnant CL (Watson et al., 2000) . There has not been a description of normal StAR expression reported throughout the estrous cycle of the cyclic mare. In ewes, StAR concentrations peak early in the estrous cycle (Juengel et al., 1995) and decline steadily from d 3 to 15 (Juengel and Niswender, 1999) . In this experiment, abundance of mRNA encoding StAR decreased after d 12 in the mare. The observed decline in mRNA for StAR occurred at the same time that a decrease in serum progesterone was detected, and values for mRNA encoding StAR were positively correlated to serum con-centrations of progesterone on d 5 and 14. These data correspond to information collected in other species that indicate that StAR plays a rate-limiting role in steroidogenesis (Stocco and Clark, 1996b) .
Concentrations of mRNA for 3β-HSD have not been reported in the equine CL. In the ewe, luteal mRNA encoding 3β-HSD increases from d 3 to 9 and declines thereafter until d 15 (Juengel and Niswender, 1999) . A similar trend was observed in equine luteal tissue. Although there was no difference in abundance of mRNA for 3β-HSD in samples collected from d 2 until d 12, there was a decline by d 14. There were also positive correlations between mRNA for 3β-HSD and concentrations of progesterone on d 5 and 12. Serum concentration of progesterone is highly correlated with abundance of mRNA encoding StAR and 3β-HSD in ewes after PG injection (Juengel et al., 2000) . In other species, 3β-HSD is not rate-limiting in progesterone production and 3β-HSD activity appears to be in great excess (Couët et al., 1990; Juengel et al., 1994) . In response to exogenous PG, it has been reported that mRNA for 3β-HSD decreases significantly in ewes (Juengel et al., 1998) and cows (Tian et al., 1994) . These equine luteal samples also demonstrated a trend toward a decline in abundance of mRNA for 3β-HSD at the time of luteolysis.
Although it appeared that the greatest abundance of mRNA for cox-2 in the biopsy samples occurred on d 2, this was not different than the cox-2 abundance detected in the samples collected on the remaining days, likely due to variability in samples. Others have reported increased abundance of mRNA encoding cox-2 in early CL of other species. In cattle, secretion of PG and abundance of mRNA for cox-2 are greatest in the early luteal phase (Kobayashi et al., 2002) . Treatment with indomethacin, which blocks production of PG, can block the formation of CL in the cow (Milvae and Hansel, 1985) , which illustrates the importance of PG in formation and early function of CL. There have been reports of mRNA encoding cox-2 increasing in mature bovine CL after a luteolytic dose of exogenous PG Wiltbank, 1997, 1998; Diaz et al., 2000; Narayansingh et al., 2002) , but this increase may be transient (Tsai et al., 2001 ). An increase in mRNA for cox-2 might also have been expected at the time of luteolysis in mares, but the sampling frequency may not have been adequate to detect transiently increased abundance of mRNA. Equine mRNA encoding cox-2 contains numerous repeats of the Shaw-Kamen's sequence, which is typically present in mRNA with short half-lives (Boerboom and Sirois, 1998) ; thus, increases in the abundance of this mRNA could be difficult to detect.
Finally, there was no difference in abundance of mRNA encoding caspase-3 between any of the days sampled. Ferriera-Dias et al. (2007) reported increasing caspase-3 protein in CL collected from mares in the mid-or late-luteal phase compared with corpora hemorrhagica. Caspase-3 has been described primarily in CL of other species in relation to luteolysis. Caspase-3-deficient mice undergo functional regression of their CL, but structural regression fails to occur (Carambula et al., 2002) . Treatment with exogenous PG increases luteal abundance of mRNA for caspase-3 at 12 and 24 h postinjection in ewes (Rueda et al., 1999) . Levels of mRNA encoding caspase-3 have not been described in natural luteolysis, and it is entirely possible that any increase was transient and thus not detected in the current experiment.
This experiment demonstrated that collecting serial biopsies of luteal tissue from cyclic mares had no detrimental effects on CL function or size. It provides the first description of luteal abundance of mRNA encoding StAR, 3β-HSD, cox-2, and caspase-3 in the cyclic mare.
